Varian Medical Systems (VAR) – Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for Varian Medical Systems (NYSE: VAR):

  • 1/29/2018 – Varian Medical Systems was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Varian Medical ended the first-quarter of fiscal 2018 on a favorable note, beating the Zacks Consensus Estimate on both the counts. Further, a solid guidance for fiscal 2018 instills confidence in the stock. Strong revenue opportunity from Oncology and Imaging Component products, growing adoption of Particle Therapy and strong overseas presence, particularly in the emerging countries are positives. Over the past six months, Varian Medical has had an impressive performance on the bourses, trading above the broader industry. However, lackluster performance by the particle therapy unit has been a concern. The company competes with large electronic companies as well as smaller and more specialized radiation therapy equipment manufacturers. Thus, cut-throat competition in the niche space is likely to mar revenues. Intensifying competition is expected to increase R&D expenditures, which will keep margins under pressure. “
  • 1/28/2018 – Varian Medical Systems had its “hold” rating reaffirmed by analysts at BTIG Research.
  • 1/25/2018 – Varian Medical Systems had its price target raised by analysts at JPMorgan Chase & Co. from $88.00 to $105.00. They now have a “neutral” rating on the stock.
  • 1/25/2018 – Varian Medical Systems was upgraded by analysts at Barrington Research from a “market perform” rating to an “outperform” rating. They now have a $130.00 price target on the stock.
  • 1/25/2018 – Varian Medical Systems had its price target raised by analysts at Citigroup Inc from $128.00 to $132.00. They now have a “buy” rating on the stock.
  • 1/25/2018 – Varian Medical Systems had its price target raised by analysts at Royal Bank of Canada to $115.00. They now have a “sector perform” rating on the stock.
  • 1/25/2018 – Varian Medical Systems was downgraded by analysts at Goldman Sachs Group Inc from a “neutral” rating to a “sell” rating. They now have a $98.00 price target on the stock.
  • 1/3/2018 – Varian Medical Systems is now covered by analysts at Evercore ISI. They set an “underperform” rating and a $100.00 price target on the stock.

Shares of Varian Medical Systems, Inc. (NYSE VAR) opened at $114.50 on Monday. Varian Medical Systems, Inc. has a one year low of $79.64 and a one year high of $130.29. The company has a market capitalization of $10,490.00, a PE ratio of 82.37, a PEG ratio of 3.32 and a beta of 0.81.

Varian Medical Systems (NYSE:VAR) last issued its earnings results on Wednesday, January 24th. The medical equipment provider reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.06. Varian Medical Systems had a return on equity of 27.13% and a net margin of 4.27%. The firm had revenue of $678.50 million for the quarter, compared to the consensus estimate of $633.96 million. During the same quarter in the prior year, the business earned $1.09 earnings per share. The company’s revenue was up 12.8% compared to the same quarter last year. analysts forecast that Varian Medical Systems, Inc. will post 4.31 earnings per share for the current fiscal year.

In related news, EVP Kolleen T. Kennedy sold 2,018 shares of the company’s stock in a transaction dated Wednesday, December 13th. The stock was sold at an average price of $111.97, for a total value of $225,955.46. Following the completion of the transaction, the executive vice president now owns 27,749 shares of the company’s stock, valued at approximately $3,107,055.53. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Dow R. Wilson sold 24,000 shares of the company’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $126.73, for a total value of $3,041,520.00. Following the completion of the transaction, the insider now directly owns 90,776 shares of the company’s stock, valued at approximately $11,504,042.48. The disclosure for this sale can be found here. Insiders sold 137,821 shares of company stock worth $15,706,135 in the last 90 days. Company insiders own 0.78% of the company’s stock.

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Receive News & Ratings for Varian Medical Systems Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply